Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02207855 · ClinicalTrials.gov registry record

Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants

A clinical trial of Anesthesia, sponsored by Joseph D. Tobias.

Completed
Registry status
21
Enrollment target
1
Study location

NCT02207855 is a study of Anesthesia that has completed, run by Joseph D. Tobias. The registered enrollment target is 21 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02207855, a study of Anesthesia, has completed, sponsored by Joseph D. Tobias.

COMPLETED
Registry status
21 participants
Enrollment target
1
Study location

Study Summary

This a study to retrospectively review our experience with the use of chloroprocaine for postoperative epidural infusions in neonates and infants. Pain scores and the need for intravenous analgesic agents will be recorded from the records to demonstrate the efficacy of the technique.

Conditions Studied

Interventions

  • DRUG Chloroprocaine

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2014-06
Est. Completion 2015-03

Sponsor

Joseph D. Tobias

21 total trials

What the Registry Record Tells You About NCT02207855

The ClinicalTrials.gov registry entry for NCT02207855 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is Joseph D. Tobias, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which Chloroprocaine is the first listed.

NCT02207855 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02207855 about?

NCT02207855 is a clinical study titled "Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants". This a study to retrospectively review our experience with the use of chloroprocaine for postoperative epidural infusions in neonates and infants. Pain scores and the need for intravenous analgesic agents will be recorded from the records to demonstrate the efficacy of the technique.

What is the current status of trial NCT02207855?

This trial is currently completed. The enrollment target is 21 participants. The study started on 2014-06. Estimated completion is 2015-03.

What conditions does trial NCT02207855 study?

This clinical trial studies the following conditions: Anesthesia.

What interventions are being tested in trial NCT02207855?

The interventions under investigation include: Chloroprocaine (DRUG).

Who is sponsoring clinical trial NCT02207855?

This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02207855 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.